Home › Myasthenia Gravis › Oregon › Portland
Myasthenia Gravis clinical trials in Portland, OR
6 studies for Myasthenia Gravis are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
RecruitingPhase 2
- University of Oregon, Portland
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- Oregon Health & Science University, Portland
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
RecruitingPhase 2/3
- Oregon Health & Science University, Portland
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RecruitingPhase 1
- Oregon Health & Science University (OHSU), Portland
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
RecruitingObservational study
- Oregon Health and Science University, Portland
- University of Colorado Hospital, Portland
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RecruitingHealthy volunteers welcome
- OHSU, Portland
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL12 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Boca Raton, FL10 studies
- Columbus, OH8 studies
- Milwaukee, WI7 studies
- St. Louis, MO7 studies
- New York City, NY7 studies
- Miami, FL7 studies
- Columbia, MO6 studies
- Orange, CA6 studies
- Jacksonville, FL6 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Prostate Cancer33 studies
- Breast Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.